Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3024% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Endoscopy by Quarter
Endoscopy (Surgical Visualization, Sports Medicine, Communications & Sustainability) — Worldwide Net Sales ($M) ($M)
Stryker Endoscopy: $1,021M in Q3 2026, up 14.0% from a year earlier.
Latest, Q3 2026
1,021
Period ended Sep 30, 2026
Change on a year earlier
+14.0%
896 in Q3 2025
History
45 quarters
Since Q4 2014
Sources
41
Documents cited below
Where the Q3 2026 figure comes from
Reported in Stryker Form 8-K Supplemental Sales Schedules, Recast 8-K & Form 10-K/10-Q Note 15.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up endoscopy
- Endoscopy (Surgical Visualization, Sports Medicine, Communications & Sustainability) — Worldwide Constant Currency Sales Growth YoY (%)14.0% · Q3 2026
- Endoscopy (Surgical Visualization, Sports Medicine, Communications & Sustainability) — Worldwide Reported Sales Growth YoY (%)13.9% · Q3 2026
- Endoscopy (Surgical Visualization, Sports Medicine, Communications & Sustainability) — U.S. Net Sales ($M)839 · Q3 2026
- Endoscopy (Surgical Visualization, Sports Medicine, Communications & Sustainability) — International Net Sales ($M)182 · Q3 2026
Cite this data
StockData. (2026). Stryker Endoscopy ($M), quarterly Q4 2014–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/fran-endo-ww-rev
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.